Bandingkan Harga & Kinerja Organon Pharma Indonesia Tbk. (SCPI) vs Trikomsel Oke Tbk. (TRIO)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Organon Pharma Indonesia Tbk. dan Trikomsel Oke Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Trikomsel Oke Tbk. diperdagangkan di Rp426 (kapitalisasi pasar 11,08 T). Perbedaan utamanya: Trikomsel Oke Tbk. jauh lebih besar — sekitar 106,1× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | TRIO | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 11,08 T |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →Tentang Trikomsel Oke Tbk.
PT Trikomsel Oke (the company) was established under its original name of PT Trikomsel Citrawahana based on Notarial Deed No. 11 dated August 21, 1996 of Mrs. Liliana Indrawati Tanuwidjaja, S.H.The Companys articles of association has been amended several times, most recently by notarial deed No. 25 of Fathiah Helmi, S.H., dated Oct 29, 2008, concerning among others, the change in the Company’s authorized stock and paid-up capital
Selengkapnya di halaman TRIO →
